Actionable insights straight to your inbox

Equities logo

11 New IPOs Totalling $1.8 Billion for Week of November 3

Full IPO calendar & reports HERE. In order of largest IPO first.  (1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market

Full IPO calendar & reports HERE. In order of largest IPO first. 

(1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market capitalization of $3 billion at a price range midpoint of $20 for Wednesday, Nov. 5, 2014.

AM is a growth-oriented limited partnership formed by Antero Resources Corporation (NYSE: AR) to own, operate and develop midstream energy assets to service Antero's rapidly increasing production.

(2) Based in Raleigh, NC,INC Research Holdings  ($INCR) scheduled a $150 million IPO on Nasdaq with a market capitalization of $915 million at a price range midpoint of $18.50 for Friday, Nov. 7, 2014.

INCR is a leading global CRO based on revenues and are exclusively focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.

(3) Based in Hong Kong,Sky Solar Holdings, Ltd. ($SKYS) scheduled a $138 million IPO on Nasdaq with a market capitalization of $604 million at a price range midpoint of $11 for Friday, Nov. 7, 2014.

SKYS has focused on the downstream solar market since its inception and has developed projects in Asia, South America, Europe, North America and Africa.

(4) Based in Seacaucus, NJ,Freshpet ($FRPT) scheduled a $135 million IPO on Nasdaq with a market capitalization of $413 million at a price range midpoint of $13 for Friday, Nov. 7, 2014.

As of June 30, 2014, Freshpet Fridges were located in over 12,500 stores, and FRPT believes there is an opportunity to install a Freshpet Fridge in at least 35,000 stores across North America.

(5) Based in Dallas, TX,Triumph Bancorp  ($TBK) scheduled a $101 million IPO on Nasdaq with a market capitalization of $249 million at a price range midpoint of $15 for Friday, Nov. 7, 2014.

TBK is a financial holding company headquartered in Dallas, Texas and registered under the BHC Act

(6) Based in Menlo Park, CA,Nevro ($NVRO) scheduled a $100 million IPO on NYSE with a market capitalization of $468 million at a price range midpoint of $16 for Thursday, Nov. 6, 2014.

NVRO is a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain.

(7) Based in Redwood City, CA,Coherus BioSciences ($CHRS) scheduled an $85 million IPO on Nasdaq with a market capitalization of $433 million at a price range midpoint of $13.50 for Thursday, Nov. 6, 2014.

CHRS is a late-stage clinical biologics platform company focused on the global biosimilar market.

CHRS is currently enrolling two Phase 3 clinical trials with CHS-0214 in rheumatoid arthritis and psoriasis which, if positive, should support the planned filing of a marketing application in Europe in 2016.

CHRS has partnered with Baxter International, Inc., Baxter Healthcare Corporation and Baxter Healthcare SA, or together, Baxter, and Daiichi Sankyo Company, Limited, or Daiichi Sankyo, in key markets outside of the United States

(8) Based in Boston, MA,Radius Bancorp ($RADB) scheduled a $64 million IPO on Nasdaq with a market capitalization of $71 million at a price range midpoint of $12.75 for the week of November 3, 2014.

RADB is the holding company for First Trade Union Bank, or the Bank, which is headquartered in Boston, Massachusetts.

(9) Based in Austin, TX,Upland Software  ($UPLD) scheduled a $50 million IPO on Nasdaq with a market capitalization of $187 million at a price range midpoint of $13 for Thursday, Nov. 6, 2014.

UPLD is a leading provider of cloud-based enterprise work management software. UPLD defines enterprise work management software as software applications that enable organizations to plan, manage and execute projects and work.

(10) Based in San Francisco, CA,Jaguar Animal Health  ($JAGX) scheduled a $40 million IPO on Nasdaq with a market capitalization of $80 million at a price range midpoint of $8 for Wednesday, Nov. 5, 2014.

JAGX is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals. Canalevia is JAGX’s lead prescription drug product candidate for the treatment of various forms of watery diarrhea in dogs.

(11) Based in Scottsdale, AZ,The Joint Corp. ($JYNT) scheduled a $30 million IPO on Nasdaq with a market capitalization of $92 million at a price range midpoint of $10 for the week of November 3, 2014.

JYNT is a rapidly growing franchisor of chiropractic clinics that operates on a non-insurance, cash-based model. JYNT seeks to be the leading provider of chiropractic care in the markets JYNT serves.

Any change significant enough to matter draws vigorous opposition from those who depend on the status quo.